Abstract #5572: Small molecular inhibitor of centromere-associated protein E (CENP-E), GSK923295A inhibits cell growth in breast cancer cells
Zhi Hu(Oregon Health & Science University), Joe W. Gray(University of Newcastle Australia), Heidi S. Feiler(Oregon Health & Science University), Richard Wooster(GlaxoSmithKline (United States)), Debopriya Das(Lawrence Berkeley National Laboratory), Sanchta Bhattacharya, Shenda Gu, Safiyyah Ziyad(Bristol-Myers Squibb (United States)), Wen‐Lin Kuo(Lawrence Berkeley National Laboratory), Barbara L. Weber, Nicholas Wang(Oregon Health & Science University), Andrew J. Wyrobek(Lawrence Berkeley National Laboratory)
Cancer Research
May 1, 2009
Cited by 1
Related Papers
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution
|Cell|2020|602
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
|Journal of Clinical Investigation|2012|591
Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target
|Cancer Cell|2013|571
Subtype and pathway specific responses to anticancer compounds in breast cancer
|Proceedings of the National Academy of Sciences|2011|505